Intuitive Surgical, Inc. ISRG
Set alert
At close
Pre-market · Nov 3, 7:25 AM ET
- YTD
- -22.86%
- 1 year
- -19.72%
- Open
- 439.79
- Prev close
- 432.01
- Mkt cap
- 154.34B
- Vol
- 3.81M
- Avg vol
- 2.44M
- EPS
- 8.27
- P/E
- 52.83
- Div yield
- 0.00%
More statistics
- Low
- 436.04
- High
- 446.46
- Forward P/E
- 35.08
- Beta
- 1.44
- Short ratio
- 3.49
- Inst. own
- 91.40%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 28, 2027
- 50-d avg
- 401.54
- 200-d avg
- 433.06
- 1y target
- 482.63
6M chart
Events in this range
- Jul 16, 2026Earnings: 2.8; estimate 2.51; surprise 11.55%
- Oct 20, 2026Earnings: 3; estimate 2.65; surprise 13.21%
- Oct 21, 2026Rating: Barclays · Overweight → Overweight
- Oct 21, 2026Rating: TD Cowen · Buy → Buy
- Oct 21, 2026Rating: Wells Fargo · Overweight → Overweight
- Oct 21, 2026Rating: Evercore ISI Group · In-Line → In-Line
- Oct 21, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 21, 2026Rating: Leerink Partners · Outperform → Outperform
Signals (23)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 2026 | 3 days ago |
| RSI: Overbought | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 24, 2026 | 2 months ago |
| SMA: Bearish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| SMA: Bearish | Aug 17, 2026 | 2 months ago |
| SMA: Bullish | Aug 10, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| RSI: Oversold | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 22, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 8, 2026 | 4 months ago |
Newest 20 of 23.
Key statistics
- Market cap
- 154.34B
- Enterprise value
- 145.84B
- Trailing P/E
- 52.83
- Forward P/E
- 35.08
- PEG ratio
- 2.00
- Price / sales
- 13.33
- Price / book
- 9.47
- EPS (TTM)
- 8.27
- Beta
- 1.44
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 25.54%
- Revenue (TTM)
- 11.58B
- Revenue growth
- 21.70%
- Free cash flow
- 3.43B
- Total cash
- 4.04B
- Total debt
- 0
- Return on equity
- 17.93%
- Shares outstanding
- 353.28M
- Short % of float
- 2.08%
- 50-day average
- 401.54
- 200-day average
- 433.06
Analyst view
Consensus: buy
- Target (low)
- 324.00
- Target (mean)
- 482.63
- Target (high)
- 685.00
- Strong buy7
- Buy19
- Hold6
- Sell1
- Strong sell1
Next earnings
Jan 28, 2027
Expected Jan 28, 2027. Consensus EPS estimate 2.95.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 28, 2027 | Dec 30, 2026 | 2.97 | — | — | — |
| Oct 20, 2026 | Sep 30, 2026 | 2.65 | 3.00 | +0.35 | +13.21% |
| Jul 16, 2026 | Jun 30, 2026 | 2.51 | 2.80 | +0.29 | +11.55% |
| Apr 21, 2026 | Mar 31, 2026 | 2.51 | 2.80 | +0.29 | +11.55% |
| Jan 22, 2026 | Dec 31, 2025 | 2.27 | 2.53 | +0.26 | +11.45% |
| Oct 21, 2025 | Sep 30, 2025 | 1.99 | 2.40 | +0.41 | +20.60% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | Leerink Partners | main | Outperform | Outperform |
| Oct 21, 2026 | JP Morgan | main | Overweight | Overweight |
| Oct 21, 2026 | Evercore ISI Group | main | In-Line | In-Line |
| Oct 21, 2026 | Wells Fargo | main | Overweight | Overweight |
| Oct 21, 2026 | TD Cowen | reit | Buy | Buy |
| Oct 21, 2026 | Barclays | main | Overweight | Overweight |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- intuitive.com
News
- Intuitive Appoints Aaron Martin to its Board of Directors
- Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.
- Here's How Much $100 Invested In Intuitive Surgical 20 Years Ago Would Be Worth Today
- Intuitive Surgical vs. Boston Scientific: Which Stock Is a Better Buy Now?
- ISRG Sales Jump 22%: Can Growth Stay Ahead of Procedure Volumes?
- Here's Why Intuitive Surgical, Inc. (ISRG) is a Strong Growth Stock
- Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
- Intuitive Surgical (NASDAQ:ISRG) VP Fredrik Widman Sells 4,047 Shares of Stock
- Intuitive Surgical (NASDAQ:ISRG) Director Craig Barratt Sells 1,150 Shares of Stock
- Intuitive Surgical (NASDAQ:ISRG) SVP Patricia Wadors Sells 1,078 Shares of Company Stock
Your note
Sign in to keep a note on ISRG — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BARRATT CRAIG H | Director | Sale | Oct 22, 2026 | 27,948 |
| CHARLTON HENRY L | Officer | Conversion of Exercise of derivative security | Feb 26, 2026 | 11,610 |
| GUTHART GARY S | Director | Sale | Oct 22, 2026 | 0 |
| JEDDI IMAN | Officer | Sale | May 31, 2026 | 33,112 |
| JOHNSON AMAL M | Director | Conversion of Exercise of derivative security | Apr 29, 2026 | 13,545 |
| LOEB GARY | Officer | Conversion of Exercise of derivative security | Oct 8, 2026 | 6,636 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.66% | 30,024,648 | 13.12B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.67% | 23,131,099 | 10.11B | Jun 29, 2026 |
| State Street Corporation | 4.63% | 16,063,040 | 7.02B | Jun 29, 2026 |
| Invesco Ltd. | 3.42% | 11,843,563 | 5.17B | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 3.25% | 11,256,570 | 4.92B | Jun 29, 2026 |
| Geode Capital Management, LLC | 2.46% | 8,534,767 | 3.73B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.24% | 11,243,468 | 4.91B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.65% | 9,176,409 | 4.01B | Jun 29, 2026 |
| Invesco QQQ Trust, Series 1 | 2.13% | 7,379,113 | 3.22B | Sep 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.36% | 4,707,533 | 2.06B | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.33% | 4,597,355 | 2.01B | Aug 30, 2026 |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | 1.26% | 4,370,746 | 1.91B | Sep 29, 2026 |